Caliway Biopharmaceuticals receives US FDA IND clearance for second global Phase 3 study of CBL-514

AbbVie's MAVIRET receives positive opinion from European regulator

Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours

OSE Immunotherapeutics reports positive Phase 2 ovarian cancer trial results

INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100

Allergan Aesthetics reports positive CHMP opinion recommending approval of Boey (trenibotulinumtoxinE)

Sobi reports positive topline results from Phase 3 study of pozdeutinurad in gout

Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment

Circio files new patent application for circVec gene therapy platform

BioMarin Pharmaceutical meets primary endpoint in Phase 3 study of VOXZOGO in children with hypochondroplasia

Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment

4basebio secures clinical supply agreement for Phase II immunotherapy trial

FDA approves MEKanistic Therapeutics' IND for MTX-531

Sino Biological launches XPressMAX Cell-Free Protein Synthesis Kit

Matter Bio submits first IND application for Lm-LLO-TT